+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05628376

Tracking Thoracic Cancer Evolution Through Therapy Rx EVO Observational Study of Early and Late-Stage Lung Cancer and Pleural Mesothelioma

Led by University College, London · Updated on 2026-07-13

600

Participants Needed

1

Research Sites

188 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting the TRACERx EVO program to study early and late-stage lung cancers, including non-small cell lung cancer NSCLC, small cell lung cancer SCLC, and pleural mesothelioma. This observational cohort study involves participants with these cancers and aims to collect extensive clinical and biological data to understand disease progression and outcomes. The study is sponsored by University College, London, and monitors survival outcomes over several years. Participants in this study receive standard anti-cancer treatments such as systemic therapies, radiotherapy, and surgery based on local and national guidelines. The study includes three groups early-stage resectable NSCLC, late-stage unresectable or metastatic NSCLC, and individuals with SCLC or pleural mesothelioma. Treatments vary according to clinical need and follow-up assessments occur every three months for the first two years, then every six months thereafter. Throughout the study, participants provide various biological samples including blood, tissue, urine, saliva, and stool for genomic and laboratory analyses. Researchers also collect detailed medical records and demographic information. The main outcomes measured are disease-free survival, progression-free survival, and overall survival over five years. Participants are closely followed to gather data that may help understand cancer evolution and treatment responses.

CONDITIONS

Brief Title

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

Research Team

R

Rachel Leslie

A

Aoife Walker

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here